Haemo-autologous Antegrade Repriming (HAR) as Minimum Impact Perfusion Strategy for Cardiopulmonary Bypass

Clinical trial NCT03720184 · COMPLETED

Trial details

NCT number: NCT03720184
Sponsor: Juan Blanco Morillo
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Anemia Cognitive; Disorder, Due to General Medical Condition Embolism, Air Transfusion Cardiac Disease Extracorporeal Circulation; Complications Valve Anomalies

Start date: 2018-08-15
Primary completion: 2019-09-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.